Is combination therapy for resistant vitreous seeds really essential? - reply

Affiliations

¹ Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
² Ocular Oncology Service, Wills Eye Hospital, Philadelphia, Pennsylvania.

Comment

Fariba Ghassemi et al. JAMA Ophthalmol. 2015 Feb.

. 2015 Feb;133(2):232-3.

doi: 10.1001/jamaophthalmol.2014.4657.

¹ Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
² Ocular Oncology Service, Wills Eye Hospital, Philadelphia, Pennsylvania.

No abstract available

Comment on

Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma.
Ghassemi F, Shields CL, Ghadimi H, Khodabandeh A, Roohipoor R. Ghassemi F, et al. JAMA Ophthalmol. 2014 Aug;132(8):936-41. doi: 10.1001/jamaophthalmol.2014.414. JAMA Ophthalmol. 2014. PMID: 24789622
Is combination therapy for resistant vitreous seeds really essential?
Ramanjulu R, Palanivelu MS. Ramanjulu R, et al. JAMA Ophthalmol. 2015 Feb;133(2):231-2. doi: 10.1001/jamaophthalmol.2014.4638. JAMA Ophthalmol. 2015. PMID: 25393925 No abstract available.